Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes

    ... neoplasms after allogeneic haematopoietic stem cell transplantation (HSCT) remains one of the leading causes of death. ... namely natural killer (NK) cell enrichment and adoptive T cell transfer, are emerging. Targeted therapies including vaccinations, ...

    Research Article last updated 03/02/2015 - 1:25pm.

  2. Foundation Update - August 2017

    ... anemia patient to be treated with a particular stem cell transplant protocol. The transplant occurred on August 11 and in ... to MDS ; August 24, 2017 1:00 PM EDT Don't miss these archived webinars! > Bone Marrow Failure Diseases ...

    Article last updated 09/05/2017 - 10:53am.

  3. Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience

    ... M, Pierce SA, Champlin R, Cortes J, Kantarjian H, Kadia T Original Publication Date:  ... no survival difference between IST and allogeneic stem cell transplant groups, with trend towards superior OS in the former. ...

    Research Article last updated 09/13/2017 - 7:40am.

  4. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

    ... phagocytosis, the latter due to the up-regulation of cell surface calreticulin, a prophagocytic marker. Blocking calreticulin on low ... for the cytopenias, and that up-regulation of the "don't eat me" signal CD47 on MDS myeloid progenitors is an important transition ...

    Research Article last updated 03/05/2013 - 9:20am.

  5. Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes

    ... Primary Author:  Cluzeau T Author(s):  Cluzeau T, McGraw ... has not been investigated. The HepG2 hepatoma cell line was used to investigate in vitro Epo elaboration. Serum collected ...

    Research Article last updated 10/20/2017 - 9:16am.

  6. Foundation Update - June 2017

    ... Patients June 29, 2017 Thu 1:00 PM EDT Don't miss these archived webinars! > PNH Non-Transplant ... I had six months to live unless I could find a matching stem cell donor. In Korea, where I’m originally from, much less was known about ...

    Article last updated 10/09/2017 - 2:42pm.

  7. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... phase I trial studies the side effects of donor stem cell transplant in treating patients with high risk acute myeloid leukemia. ... (with > 3 cytogenetic abnormalities), del (7q, -5, -7), t(9,22), 11q(23) or high risk mutations by FISH eg MLL, FLT-3 + ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  8. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome

    ... Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C Original ... myelodysplastic syndromes (MDS). In patients with sickle cell anemia (SCA), iron does not seem to deposit quickly in the heart. ...

    Research Article last updated 03/22/2017 - 10:46am.

  9. Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.

    ... engraftment after allogeneic haemopoietic stem cell transplant (HSCT). Its associated low incidence of GVHD makes it an ... tolerance post-HSCT with the findings of stable mixed T cell chimerism with full donor myeloid chimerism and the absence of ...

    Research Article last updated 06/20/2013 - 10:30am.

  10. Foundation Update - September 2017

    ... serious complication that can occur with cancer-related stem cell transplants. Ibrutinib may now be used in patients who fail to respond to ... Relationship ; October 10, 2017 Tue 1:00 PM EDT Don't miss these archived webinars > MDS Research Updates from ASCO ...

    Article last updated 09/12/2017 - 7:14am.